IL13 and prediabetes syndrome: The findings of a prospective study lasting 177 months in Rotterdam shown, after adjusting for multiple confounding factors, interleukin 13 (IL-13), extracellular newly identified receptor for advanced glycation end-products binding protein (EN-RAGE) and C-reactive protein (CRP) are still associated with prediabetes.